Chief Financial Officer · Tyra Biosciences, Inc. (TYRA)

Alan Fuhrman

FY2023 is the first fiscal year CompBrief holds for Alan Fuhrman as a named executive officer of Tyra Biosciences; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2023

$3,530,805

Salary $457,600Stock awards $0

2nd of 4 named executive officers at Tyra Biosciences by FY2023 total.

4 named officers on file for Tyra Biosciences, FY2023

Alan Fuhrman’s pay file — $29

  • 1 fiscal year of pay, line by line
  • 3 equity grants, each cited to its filing

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Tyra Biosciences’s whole pay program stands against its peers

  • Tyra Biosciences’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on TYRA→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 18, 2024 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get Alan Fuhrman’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Alan Fuhrman compensation by year

Tyra Biosciences Summary Compensation Table · the one fiscal year held
In US dollars, as Tyra Biosciences reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2023
Salary$457,600
Bonus$0
Stock awards$0
Option awards$2,767,712
Non-equity incentive$274,560
Pension and deferred compensation$0
All other$30,933
Total$3,530,805

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Tyra Biosciences, Inc. DEF 14A filed April 18, 2024, accession 0001193125-24-100755, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Tyra Biosciences, Inc. filed document, accession 0001193125-24-100755. Every figure is read from that document and cited to the page and table it appears in. Filed April 18, 2024.

Equity holdings

unvested awards at FY2023 year-end
TypeUnvested unitsValue at year-endExercise price
Option62,685—$14.35
Option328,000—$7.60
Option32,800—$7.60

Per the Outstanding Equity Awards at Fiscal Year-End table in Tyra Biosciences, Inc.'s FY2023 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

7 Form 4 lines since the FY2023 proxy (filed April 18, 2024)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2026-09-15Grant or award—951$9.1337,115
2026-05-05Grant or award derivative—67,000$0.0067,000
2026-05-05Grant or award—20,000$0.0036,164
2026-03-13Grant or award—1,376$9.1316,164
2025-09-15Grant or award—701$9.1314,788
2025-08-07Grant or award derivative—170,000$0.00170,000
2025-03-14Grant or award—1,238$9.7814,087

The 7 most recent of 7 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

Tyra Biosciences’s named executive officers, FY2023

as the company reported each
Named executive officerRoleFY2023 total
Todd HarrisChief Executive Officer$4,626,119
Alan Fuhrman · this pageChief Financial Officer$3,530,805
Hiroomi TadaChief Medical Officer$2,412,417
Daniel BensenChief Operating Officer$1,919,933

The full Tyra Biosciences compensation record

free company brief

This page is one person within Tyra Biosciences's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Tyra Biosciences's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Alan Fuhrman's compensation dossier · One-time report. No refunds.